3 results

• Cancer Drug Copiktra Linked To Increased Risk of Death, FDA Warns

  July 1, 2022

  Martha Garcia

  The FDA warns the cancer drug, Copiktra, may be linked to an increased risk of death among patients.

• Ukoniq Side Effects Linked to Increased Risk of Death, FDA Warns, Withdraws Drug Approval

  June 3, 2022

  Irvin Jackson

  The FDA has withdrawn approval for the lymphoma drug Ukoniq after determining the risk of death outweighs any potential benefits.

• Ukoniq FDA Warning Issued Over Increased Risk of Death with Cancer Drug

  February 4, 2022

  Irvin Jackson

  The FDA warns that the relatively new cancer drug, Ukoniq, may increase the risk of death in the lymphoma patients it was designed to treat.